Lanean...
Anti-RNPC3 Antibodies as a Marker of Cancer-Associated Scleroderma
INTRODUCTION: Prior studies have demonstrated an increased risk of cancer-associated scleroderma in patients with RNA polymerase III (POL) autoantibodies and in patients negative for anti-centromere (CENP), anti-topoisomerase-1 (TOPO), and anti-POL antibodies (referred to as CENP/TOPO/POL (CTP)-Nega...
Gorde:
| Argitaratua izan da: | Arthritis Rheumatol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5449218/ https://ncbi.nlm.nih.gov/pubmed/28217959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40065 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|